Literature DB >> 23732628

Convenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of metformin.

Kristiina M Huttunen1, Jukka Leppänen, Krista Laine, Jouko Vepsäläinen, Jarkko Rautio.   

Abstract

A convenient microwave-assisted synthesis of lipophilic sulfenamide prodrugs of antidiabetic agent, metformin, is reported in this study. These acyclic prodrugs were synthesized directly from selected disulfides with basic metformin and silver nitrate by a one-pot reaction under microwave irradiation. The prepared prodrugs had significantly increased lipophilicity, which resulted in excellent permeability of the octylthio prodrug of metformin across a Caco-2 cell monolayer. According to our preliminary in vivo studies, the octylthio prodrug was also absorbed mostly intact after oral administration in rats. In conclusion, this study shows that these types of more lipophilic sulfenamide prodrugs can be promising candidates to improve permeability and passive absorption of highly water-soluble metformin.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lipophilic; Metformin; Microwave-assisted synthesis; Prodrug; Sulfenamide

Mesh:

Substances:

Year:  2013        PMID: 23732628     DOI: 10.1016/j.ejps.2013.05.023

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

Review 1.  Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.

Authors:  Magdalena Markowicz-Piasecka; Joanna Sikora; Aleksandra Szydłowska; Agata Skupień; Elżbieta Mikiciuk-Olasik; Kristiina M Huttunen
Journal:  Pharm Res       Date:  2017-06-06       Impact factor: 4.200

2.  Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity.

Authors:  Magdalena Markowicz-Piasecka; Joanna Sikora; Łukasz Mateusiak; Elżbieta Mikiciuk-Olasik; Kristiina M Huttunen
Journal:  Oxid Med Cell Longev       Date:  2017-07-09       Impact factor: 6.543

3.  Sulfenamide and Sulfonamide Derivatives of Metformin - A New Option to Improve Endothelial Function and Plasma Haemostasis.

Authors:  Magdalena Markowicz-Piasecka; Kristiina M Huttunen; Marlena Broncel; Joanna Sikora
Journal:  Sci Rep       Date:  2019-04-25       Impact factor: 4.379

Review 4.  Deciphering the Roles of Metformin in Alzheimer's Disease: A Snapshot.

Authors:  Wang Liao; Jiaxin Xu; Bo Li; Yuting Ruan; Tian Li; Jun Liu
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

Review 5.  Type 2 Diabetes Complicated With Heart Failure: Research on Therapeutic Mechanism and Potential Drug Development Based on Insulin Signaling Pathway.

Authors:  Hui Ye; Yanan He; Chuan Zheng; Fang Wang; Ming Yang; Junzhi Lin; Runchun Xu; Dingkun Zhang
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

6.  Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation.

Authors:  Magdalena Markowicz-Piasecka; Kristiina M Huttunen; Joanna Sikora
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

7.  Pleiotropic Activity of Metformin and Its Sulfonamide Derivatives on Vascular and Platelet Haemostasis.

Authors:  Magdalena Markowicz-Piasecka; Kristiina M Huttunen; Adrianna Sadkowska; Joanna Sikora
Journal:  Molecules       Date:  2019-12-28       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.